ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustrySchlierenVirometix AG
Virometix AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of Virometix AG is the development of pharmaceuticals and therapeutics, particularly in the fields of oncology and virology, using live biotherapeutics and other innovative technologies.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Virometix AG

✓ Offered5
Technology platform for synthetic vaccines
Structure-based, fully synthetic nanoparticle vaccines to elicit targeted, robust and long-lasting immune responses; SVLP platform with synthetic peptidomimetics, built-in adjuvants and simplified manufacturing.
Pneumococcal vaccine candidate V-212
Serotype-independent, fully synthetic vaccine candidate against Streptococcus pneumoniae with conserved epitopes on SVLP nanoparticles; studied preclinically for broad immunity against different serotypes.
RSV vaccine candidate
Epitope-specific vaccine candidate against Respiratory Syncytial Virus (RSV) based on the SVLP platform; candidate V-306 was described in a Phase I study as safe, well tolerated and immunogenic.
Co-development partnerships for vaccine development
Co-development partnerships for vaccines against pneumococcus, cervical cancer, respiratory viruses and other selected infectious or chronic diseases.
SVLP technology partnerships and R&D collaborations
Technology partnerships around the SVLP platform as well as R&D collaborations in the areas of monoclonal antibodies, formulation of biologics and peptides, and drug delivery.
Trust & reputation

ranQ Trust Score of Virometix AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

Virometix AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Virometix AG scores 89.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Virometix AG scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
Virometix AG scores 36.5 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.22.94%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.50.04%
Qualifications+0.00

Virometix AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

November 13, 2025Media
Virometix completes $15 million financing round
startupticker.ch
July 23, 2020Media
Biotech startup Virometix obtains CHF 7.5 M in a series B round
startupticker.ch
March 16, 2020Media
Virometix to kick off in-human studies of its first vaccine candidate
startupticker.ch
February 4, 2019Media
Anna Sumeray takes the lead at Virometix
startupticker.ch

Knowledge

No knowledge articles yet

Once Virometix AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Virometix AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Virometix AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Virometix AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Wagistrasse 14
8952 Schlieren

At a glance

Legal form
Corporation
UID
CHE-115.105.074
Founded
2009 · 17 years
Last commercial register change
July 13, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    LB
    LimmaTech Biologics AG
    Schlieren
    RA
    Redbiotec AG
    Schlieren
    MA
    Mabylon AG
    Schlieren
    BA
    Baxiva AG
    Schlieren
    AH
    AeoniQ Holding AG
    Schlieren
    MP
    Molecular Partners AG
    Schlieren
    CA
    CDR-Life AG
    Horgen
    DT
    Denali Therapeutics CH GmbH
    Zurich